Menu

woman with stack of papers in hand, speaking to unseen person

Financials & Compliance

More than five decades of financial stability, so programs can launch, deepen and grow.

For more than five decades, PHI has served as the fiscal agent for the innovative projects it supports and the dynamic public health leaders it attracts. PHI remains committed to financial integrity, transparency, and stability, and to leveraging resources, partnerships and collaboration to maximize advances that improve public health and well-being in the U.S. and around the world. PHI serves as a comprehensive fiscal sponsor for initiatives that scale from a single committed researcher to programs with more than 100 staff, and manages awards from 300+ funding sources. PHI has a history of receiving unqualified opinions on its audits—an important designation that indicates financial compliance and transparency, and which makes PHI competitive for federal and other funding streams.

Work With Us Partner with PHI

2022 Financial Snapshot

Revenue

Grants and Contracts244,805,160
Other revenue108,289
Total 244,913,449

Expenses

Research and program services 215,231,406
Management and general 28,406,5578
Total 243,637,984

Net Asssets

Net assets at beginning of year 49,806,378
Net assets released from restriction2,042,490
Change in unrestricted net assets(767,024)
Total51,081,844
  • 90% Direct Research & Program Services
  • 10% Management and General Rate
  • < 1% Fundraising

The information presented here is drawn from PHI’s financial statements, prepared by independent auditors Crowe LLP, Certified Public Accountants.

Financial Statements and Reviews

Compliance

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org